FDA and Life Sciences FDA Finalizes Guidances for “Consistent Communications” and Payor Communications

King & Spalding

A Summary of Final Guidances for Communications That Are Consistent with FDA-Required Labeling and Communications with Payors -

On June 12, 2018, the Food and Drug Administration (FDA or Agency) finalized two draft guidance documents that have been closely watched:

(1) Medical Product Communications That Are Consistent With the FDA-Required Labeling – Questions and Answers[hereinafter “CFL Guidance”].

The CFL Guidance addresses how the Agency will treat information that is “consistent” with, but not contained in, FDA-required labeling (often referred to as “consistent communications” or “CFL communications”).

Please see full Alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Written by:

King & Spalding

King & Spalding on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.